Diagnostic performance of microvascular flow imaging for noninvasive assessment of liver fibrosis in chronic liver disease.

ABSTRACT:

Background and aims

Chronic liver disease (CLD) represents a significant global health challenge necessitating the evaluation of liver fibrosis. This study aimed to evaluate the diagnostic performance of microvascular flow (MV-flow) imaging in evaluating liver fibrosis and compare it with other non-invasive tools.

Methods

Between July 2020 and June 2022, we prospectively enrolled patients scheduled for liver biopsy, concurrently measuring MV-flow imaging, transient elastography (TE), and two-dimensional shear wave elastography (2D-SWE) as part of the assessment process. We evaluated the diagnostic performance of MV-flow imaging, 2D-SWE, and TE based on histologic staging of liver fibrosis using the area under the receiver operating characteristic curve (AUROC), and calculate

SUBMITTER: Yoo HW 

PROVIDER: S-EPMC12136292 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature